Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy.
Meagher MF, Minervini A, Mir MC, Cerrato C, Rebez G, Autorino R, Hampton L, Campi R, Kriegmair M, Linares E, Hevia V, Musquera M, D'Anna M, Roussel E, Albersen M, Pavan N, Claps F, Antonelli A, Marchioni M, Paksoy N, Erdem S, Derweesh IH. Meagher MF, et al. Among authors: rebez g. Eur Urol Open Sci. 2024 Mar 25;63:71-80. doi: 10.1016/j.euros.2024.02.001. eCollection 2024 May. Eur Urol Open Sci. 2024. PMID: 38572300 Free PMC article.
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Erdem S, Bertolo R, Campi R, Capitanio U, Amparore D, Anceschi U, Mir MC, Roussel E, Pavan N, Carbonara U, Kara O, Klatte T, Marchioni M, Pecoraro A, Muselaers S, Marandino L, Diana P, Borregales L, Palumbo C, Warren H, Wu Z, Calio A, Ciccarese C, Degirmenci E, Aydin R, Rebez G, Schips L, Simone G, Minervini A, Serni S, Ozcan F. Erdem S, et al. Among authors: rebez g. Urol Oncol. 2024 May;42(5):163.e1-163.e13. doi: 10.1016/j.urolonc.2024.01.028. Epub 2024 Mar 5. Urol Oncol. 2024. PMID: 38443238
Personalised indocyanine-guided lymphadenectomy for prostate cancer: a randomised clinical trial.
de Pablos-Rodríguez P, Claps F, Rebez G, Vidal Crespo N, Gómez-Ferrer Á, Mascarós JM, Collado Serra A, Caltrava Fons A, Rubio-Briones J, Casanova Ramon Borja J, Ramírez Backhaus M. de Pablos-Rodríguez P, et al. Among authors: rebez g. BJU Int. 2023 Nov;132(5):591-599. doi: 10.1111/bju.16117. Epub 2023 Jul 18. BJU Int. 2023. PMID: 37410659 Clinical Trial.
Assessing Trifecta Achievement after Percutaneous Cryoablation of Small Renal Masses: Results from a Multi-Institutional Collaboration.
Piasentin A, Claps F, Silvestri T, Rebez G, Traunero F, Mir MC, Rizzo M, Celia A, Cicero C, Urbani M, Balestreri L, Pola L, Laganà F, Cernic S, Cova MA, Bertolotto M, Trombetta C, Liguori G, Pavan N. Piasentin A, et al. Among authors: rebez g. Medicina (Kaunas). 2022 Aug 3;58(8):1041. doi: 10.3390/medicina58081041. Medicina (Kaunas). 2022. PMID: 36013508 Free PMC article.
Stereotactic body radiation therapy in patients with metachronous oligorecurrent prostate cancer: A single-center experience.
de Pablos-Rodríguez P, la Rosa A, Rebez G, Mascarós Martínez JM, González Pérez V, Arribas Alpuente L, Rubio-Briones J, Ramírez-Backhaus M. de Pablos-Rodríguez P, et al. Among authors: rebez g. Actas Urol Esp (Engl Ed). 2022 May;46(4):238-244. doi: 10.1016/j.acuroe.2021.12.009. Epub 2022 Mar 20. Actas Urol Esp (Engl Ed). 2022. PMID: 35321821 English, Spanish.
External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: A multi-institutional analysis.
Erdem S, Capitanio U, Campi R, Mir MC, Roussel E, Pavan N, Kara O, Klatte T, Kriegmair MC, Degirmenci E, Aydin R, Minervini A, Serni S, Berni A, Rebez G, Ozcan F; European Association of Urology (EAU)-Young Academic Urologists (YAU) Renal Cancer Working Group. Erdem S, et al. Among authors: rebez g. Urol Oncol. 2022 May;40(5):198.e9-198.e17. doi: 10.1016/j.urolonc.2022.01.006. Epub 2022 Feb 13. Urol Oncol. 2022. PMID: 35172939
15 results